Endocrinology, Vol 135, 38-44, Copyright © 1994 by Endocrine Society

ARTICLES

An insulin-like growth factor-II (IGF-II) analog with highly selective affinity for IGF-II receptors stimulates differentiation, but not IGF-I receptor down-regulation in muscle cells

SM Rosenthal, D Hsiao and LA Silverman
Department of Pediatrics, University of California, San Francisco 94143.

The insulin-like growth factors (IGFs) stimulate the growth and differentiation of muscle cells. IGF-II, the principal IGF peptide expressed by differentiating muscle cells, has been implicated in at least two autocrine/paracrine actions in this tissue: stimulation of differentiation and down-regulation of the IGF-I receptor. To determine which IGF receptor subtypes mediate these effects of IGF-II, we treated mouse BC3H-1 muscle cells with native IGF-II or [Leu27]IGF-II, an analog with high affinity for IGF-II receptors (comparable to that seen with native IGF-II) but markedly reduced affinity for IGF-I and insulin receptors. Muscle cell differentiation was assessed by the expression of myogenin mRNA and by the binding of alpha-bungarotoxin to the nicotinic acetylcholine receptor. IGF-I receptor down-regulation was assessed by receptor binding and mRNA abundance. Although less potent than IGF-II, the [Leu27]IGF-II analog stimulated myogenin gene expression and acetylcholine receptor binding in concentrations at which the analog interacted with IGF-II receptors, but not significantly with IGF-I receptors. In IGF-I receptor down-regulation studies, IGF-II pretreatment significantly decreased binding of IGF-I to the IGF-I receptor and decreased IGF-I receptor mRNA, whereas the IGF-II analog had only minimal effects. Thus, in addition to the IGF-I receptor which has been previously found to signal IGF-induced myogenesis, these results implicate a role for the IGF-II receptor in this process. In contrast, IGF-I receptor down-regulation induced by IGF-II is mediated through IGF-I, but not IGF-II, receptors in muscle cells.

This article has been cited by other articles:

				C. Hawkes, J. H. Jhamandas, K. H. Harris, W. Fu, R. G. MacDonald, and S. Kar Single Transmembrane Domain Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor Regulates Central Cholinergic Function by Activating a G-Protein-Sensitive, Protein Kinase C-Dependent Pathway J. Neurosci., January 11, 2006; 26(2): 585 - 596. [Abstract] [Full Text] [PDF]

				S. P. Kirk, J. M. Oldham, F. Jeanplong, and J. J. Bass Insulin-like Growth Factor-II Delays Early but Enhances Late Regeneration of Skeletal Muscle J. Histochem. Cytochem., December 1, 2003; 51(12): 1611 - 1620. [Abstract] [Full Text] [PDF]

				N. F. Paoni, F. Peale, F. Wang, C. Errett-Baroncini, H. Steinmetz, K. Toy, W. Bai, P. M. Williams, S. Bunting, M. E. Gerritsen, et al. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice Physiol Genomics, December 3, 2002; 11(3): 263 - 272. [Abstract] [Full Text] [PDF]

				P. Kaliman, J. Canicio, P. R. Shepherd, C. A. Beeton, X. Testar, M. Palacín, and A. Zorzano Insulin-like Growth Factors Require Phosphatidylinositol 3-Kinase to Signal Myogenesis: Dominant Negative p85 Expression Blocks Differentiation of L6E9 Muscle Cells Mol. Endocrinol., January 1, 1998; 12(1): 66 - 77. [Abstract] [Full Text]

				S. Kar, D. Seto, S. Dore, U.-K. Hanisch, and R. Quirion Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation PNAS, December 9, 1997; 94(25): 14054 - 14059. [Abstract] [Full Text] [PDF]

				J. C. Groskopf, L.-J. Syu, A. R. Saltiel, and D. I. H. Linzer Proliferin Induces Endothelial Cell Chemotaxis through a G Protein-Coupled, Mitogen-Activated Protein Kinase-Dependent Pathway Endocrinology, July 1, 1997; 138(7): 2835 - 2840. [Abstract] [Full Text] [PDF]

				P. Kaliman, F. Vinals, X. Testar, M. Palacin, and A. Zorzano Phosphatidylinositol 3-Kinase Inhibitors Block Differentiation of Skeletal Muscle Cells J. Biol. Chem., August 9, 1996; 271(32): 19146 - 19151. [Abstract] [Full Text] [PDF]

				G. Schwartz, M. Warren, K Sakano, J. Szabo, S. Kessler, A Pashapour, R. Gress, and J. Perdue Comparative effects of insulin-like growth factor II (IGF-II) and IGF- II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis Stem Cells, May 1, 1996; 14(3): 337 - 350. [Abstract]